Dibb Martyn J, Abraham Arun, Chadwick Paul R, Shaffer Jon L, Teubner Antje, Carlson Gordon L, Lal Simon
Intestinal Failure Unit
Intestinal Failure Unit.
JPEN J Parenter Enteral Nutr. 2016 Jul;40(5):699-704. doi: 10.1177/0148607114549999. Epub 2014 Sep 15.
Catheter-related bloodstream infections (CRBSIs) are a serious complication in the provision of home parenteral nutrition (HPN). Antibiotic salvage of central venous catheters (CVCs) in CRBSI is recommended; however, this is based on limited reports. We assessed the efficacy of antibiotic salvage of CRBSIs in HPN patients.
All confirmed CRBSIs occurring in patients receiving HPN in a national intestinal failure unit (IFU), between 1993 and 2011, were analyzed. A standardized protocol involving antibiotic and urokinase CVC locks and systemic antibiotics was used.
In total, 588 patients were identified with a total of 2134 HPN years, and 297 CRBSIs occurred in 137 patients (65 single and 72 multiple CRBSIs). The overall rate of CRBSI in all patients was 0.38 per 1000 catheter days. Most (87.9%) infections were attributable to a single microorganism. In total, 72.5% (180/248) of CRBSIs were salvaged when attempted (coagulase-negative staphylococcus, 79.8% [103/129], Staphylococcus aureus, 56.7% [17/30]; polymicrobial infections, 67.7% [21/30]; and miscellaneous, 66.1% [39/59]). CVC salvage was not attempted in 49 episodes because of life-threatening sepsis (n = 18), fungal infection (n = 7), catheter problems (n = 20), and CVC tunnel infection (n = 4). Overall, the CVC was removed in 33.7% (100/297) of cases. There were 5 deaths in patients admitted to the IFU for management of the CRBSI (2 severe sepsis at presentation, 3 metastatic infection).
This is the largest reported series of catheter salvage in CRBSIs and demonstrates successful catheter salvage in most cases when using a standardized protocol.
导管相关血流感染(CRBSIs)是家庭肠外营养(HPN)过程中的一种严重并发症。推荐对CRBSI中的中心静脉导管(CVCs)进行抗生素挽救治疗;然而,这是基于有限的报告。我们评估了抗生素挽救治疗HPN患者CRBSIs的疗效。
分析了1993年至2011年间在一个国家肠道衰竭治疗中心(IFU)接受HPN治疗的患者中所有确诊的CRBSIs。采用了包括抗生素和尿激酶CVC封管以及全身应用抗生素的标准化方案。
总共确定了588例患者,总计2134个HPN治疗年,137例患者发生了297次CRBSIs(65次单次和72次多次CRBSIs)。所有患者中CRBSI的总体发生率为每1000导管日0.38次。大多数(87.9%)感染归因于单一微生物。在尝试进行治疗时,总共72.5%(180/248)的CRBSIs得到挽救(凝固酶阴性葡萄球菌,79.8%[103/129];金黄色葡萄球菌,56.7%[17/30];混合微生物感染,67.7%[21/30];其他,66.1%[39/59])。49次发作因危及生命的脓毒症(n = 18)、真菌感染(n = 7)、导管问题(n = 20)和CVC隧道感染(n = 4)而未尝试进行CVC挽救。总体而言,33.7%(100/297)的病例中CVC被拔除。因CRBSI入住IFU治疗的患者中有5例死亡(2例就诊时为严重脓毒症,3例为转移性感染)。
这是报道的关于CRBSIs中导管挽救治疗的最大系列病例,并表明在使用标准化方案时,大多数情况下导管挽救治疗是成功的。